In patients with renal impairment, drug metabolism and excretion can be significantly altered. Although Poxet is primarily metabolized in the liver, its excretion through the kidneys means that any impairment in renal function could potentially affect drug levels in the body. This is particularly relevant for renal transplant patients, who often have compromised kidney function and are on a regimen of medications that could further influence renal clearance.
